Vanda Pharmaceuticals (VNDA) EBIT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -200.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200.23% |
| Dec 31, 2025 | -100.73% |
| Sep 30, 2025 | -115.48% |
| Jun 30, 2025 | -135.88% |
| Mar 31, 2025 | -74.90% |
| Dec 31, 2024 | -47.21% |
| Sep 30, 2024 | -44.49% |
| Jun 30, 2024 | -41.29% |
| Mar 31, 2024 | -42.49% |
| Dec 31, 2023 | -38.88% |
| Sep 30, 2023 | -40.51% |
| Jun 30, 2023 | -32.24% |
| Mar 31, 2023 | 162.23% |
| Dec 31, 2022 | 16.04% |
| Sep 30, 2022 | -28.65% |
| Jun 30, 2022 | -29.54% |
| Mar 31, 2022 | -54.31% |
| Dec 31, 2021 | -1.91% |
| Sep 30, 2021 | 20.18% |
| Jun 30, 2021 | 46.76% |
| Mar 31, 2021 | 61.79% |
| Dec 31, 2020 | 90.02% |
| Sep 30, 2020 | 52.87% |
| Jun 30, 2020 | 89.14% |
| Mar 31, 2020 | 74.90% |
| Dec 31, 2019 | 103.98% |
| Sep 30, 2019 | 164.37% |
| Jun 30, 2019 | 59.61% |
| Mar 31, 2019 | 44.90% |
| Dec 31, 2018 | 37.76% |
| Sep 30, 2018 | 38.44% |
| Jun 30, 2018 | 39.54% |
| Mar 31, 2018 | 30.79% |
| Dec 31, 2017 | -26.64% |
| Sep 30, 2017 | -50.37% |
| Jun 30, 2017 | 55.34% |
| Mar 31, 2017 | 33.25% |
| Dec 31, 2016 | 56.21% |
| Sep 30, 2016 | 50.64% |
| Jun 30, 2016 | -11.95% |
| Mar 31, 2016 | -39.81% |
| Dec 31, 2015 | -32.32% |
| Sep 30, 2015 | -20.93% |
| Jun 30, 2015 | 12.28% |
| Mar 31, 2015 | -7.36% |
| Dec 31, 2014 | 139.84% |
| Sep 30, 2014 | 23.96% |
| Jun 30, 2014 | -142.61% |
| Mar 31, 2014 | -1,460.33% |
| Dec 31, 2013 | -127.98% |
| Sep 30, 2013 | -110.37% |
| Jun 30, 2013 | -70.42% |